tetano
Editor, Senior Moderator
PLoS One
. 2024 Apr 25;19(4):e0302464.
doi: 10.1371/journal.pone.0302464. eCollection 2024. Genetic variant rs1205 is associated with COVID-19 outcomes: The Strong Heart Study and Strong Heart Family Study
Lyle G Best[SUP] 1 2 [/SUP], Esther Erdei[SUP] 3 [/SUP], Karin Haack[SUP] 4 [/SUP], Jack W Kent Jr[SUP] 4 [/SUP], Kimberly M Malloy[SUP] 5 [/SUP], Deborah E Newman[SUP] 4 [/SUP], Marcia O'Leary[SUP] 1 [/SUP], Rae A O'Leary[SUP] 1 [/SUP], Quan Sun[SUP] 6 [/SUP], Ana Navas-Acien[SUP] 7 [/SUP], Nora Franceschini[SUP] 8 [/SUP], Shelley A Cole[SUP] 4 [/SUP]
Affiliations
Background: Although COVID-19 infection has been associated with a number of clinical and environmental risk factors, host genetic variation has also been associated with the incidence and morbidity of infection. The CRP gene codes for a critical component of the innate immune system and CRP variants have been reported associated with infectious disease and vaccination outcomes. We investigated possible associations between COVID-19 outcome and a limited number of candidate gene variants including rs1205.
Methodology/principal findings: The Strong Heart and Strong Heart Family studies have accumulated detailed genetic, cardiovascular risk and event data in geographically dispersed American Indian communities since 1988. Genotypic data and 91 COVID-19 adjudicated deaths or hospitalizations from 2/1/20 through 3/1/23 were identified among 3,780 participants in two subsets. Among 21 candidate variants including genes in the interferon response pathway, APOE, TMPRSS2, TLR3, the HLA complex and the ABO blood group, only rs1205, a 3' untranslated region variant in the CRP gene, showed nominally significant association in T-dominant model analyses (odds ratio 1.859, 95%CI 1.001-3.453, p = 0.049) after adjustment for age, sex, center, body mass index, and a history of cardiovascular disease. Within the younger subset, association with the rs1205 T-Dom genotype was stronger, both in the same adjusted logistic model and in the SOLAR analysis also adjusting for other genetic relatedness.
Conclusion: A T-dominant genotype of rs1205 in the CRP gene is associated with COVID-19 death or hospitalization, even after adjustment for relevant clinical factors and potential participant relatedness. Additional study of other populations and genetic variants of this gene are warranted.
. 2024 Apr 25;19(4):e0302464.
doi: 10.1371/journal.pone.0302464. eCollection 2024. Genetic variant rs1205 is associated with COVID-19 outcomes: The Strong Heart Study and Strong Heart Family Study
Lyle G Best[SUP] 1 2 [/SUP], Esther Erdei[SUP] 3 [/SUP], Karin Haack[SUP] 4 [/SUP], Jack W Kent Jr[SUP] 4 [/SUP], Kimberly M Malloy[SUP] 5 [/SUP], Deborah E Newman[SUP] 4 [/SUP], Marcia O'Leary[SUP] 1 [/SUP], Rae A O'Leary[SUP] 1 [/SUP], Quan Sun[SUP] 6 [/SUP], Ana Navas-Acien[SUP] 7 [/SUP], Nora Franceschini[SUP] 8 [/SUP], Shelley A Cole[SUP] 4 [/SUP]
Affiliations
- PMID: 38662664
- DOI: 10.1371/journal.pone.0302464
Background: Although COVID-19 infection has been associated with a number of clinical and environmental risk factors, host genetic variation has also been associated with the incidence and morbidity of infection. The CRP gene codes for a critical component of the innate immune system and CRP variants have been reported associated with infectious disease and vaccination outcomes. We investigated possible associations between COVID-19 outcome and a limited number of candidate gene variants including rs1205.
Methodology/principal findings: The Strong Heart and Strong Heart Family studies have accumulated detailed genetic, cardiovascular risk and event data in geographically dispersed American Indian communities since 1988. Genotypic data and 91 COVID-19 adjudicated deaths or hospitalizations from 2/1/20 through 3/1/23 were identified among 3,780 participants in two subsets. Among 21 candidate variants including genes in the interferon response pathway, APOE, TMPRSS2, TLR3, the HLA complex and the ABO blood group, only rs1205, a 3' untranslated region variant in the CRP gene, showed nominally significant association in T-dominant model analyses (odds ratio 1.859, 95%CI 1.001-3.453, p = 0.049) after adjustment for age, sex, center, body mass index, and a history of cardiovascular disease. Within the younger subset, association with the rs1205 T-Dom genotype was stronger, both in the same adjusted logistic model and in the SOLAR analysis also adjusting for other genetic relatedness.
Conclusion: A T-dominant genotype of rs1205 in the CRP gene is associated with COVID-19 death or hospitalization, even after adjustment for relevant clinical factors and potential participant relatedness. Additional study of other populations and genetic variants of this gene are warranted.